CFM
BIO icon

Coronation Fund Managers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Coronation Fund Managers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,060
Closed -$5.71M – 178
2023
Q2 		$5.71M Buy
15,060
+4,419
+42% +$1.8M 0.15% 107
2023
Q1 		$5.1M Buy
+10,641
New +$4.98M 0.14% 116

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Coronation Fund Managers's BIO Position: Q3 2023 in Review

Coronation Fund Managers sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 15,060 shares — an estimated $5.71M sold.

Coronation Fund Managers first reported a position in BIO in Q1 2023 and held it in 2 quarters. The position peaked at $5.71M in Q2 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • Coronation Fund Managers reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • Coronation Fund Managers sold 15,060 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $5.71M.
  • Coronation Fund Managers first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and held it in 2 quarters.
  • Coronation Fund Managers's Bio-Rad Laboratories Class A position peaked at $5.71M in Q2 2023.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Coronation Fund Managers's 13F filing for Q3 2023, filed 18 Oct 2023.